Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12463747rdf:typepubmed:Citationlld:pubmed
pubmed-article:12463747lifeskim:mentionsumls-concept:C1882071lld:lifeskim
pubmed-article:12463747lifeskim:mentionsumls-concept:C0034135lld:lifeskim
pubmed-article:12463747lifeskim:mentionsumls-concept:C0012737lld:lifeskim
pubmed-article:12463747lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:12463747lifeskim:mentionsumls-concept:C0020276lld:lifeskim
pubmed-article:12463747lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:12463747pubmed:issue49lld:pubmed
pubmed-article:12463747pubmed:dateCreated2002-12-4lld:pubmed
pubmed-article:12463747pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:abstractTextImmucillin-H (ImmH) and immucillin-G (ImmG) were previously reported as transition-state analogues for bovine purine nucleoside phosphorylase (PNP) and are the most powerful inhibitors reported for the enzyme (K(i) = 23 and 30 pM). Sixteen new immucillins are used to probe the atomic interactions that cause tight binding for bovine PNP. Eight analogues of ImmH are identified with equilibrium dissociation constants of 1 nM or below. A novel crystal structure of bovine PNP-ImmG-PO(4) is described. Crystal structures of ImmH and ImmG bound to bovine PNP indicate that nearly every H-bond donor/acceptor site on the inhibitor is fully engaged in favorable H-bond partners. Chemical modification of the immucillins is used to quantitate the energetics for each contact at the catalytic site. Conversion of the 6-carbonyl oxygen to a 6-amino group (ImmH to ImmA) increases the dissociation constant from 23 pM to 2.6 million pM. Conversion of the 4'-imino group to a 4'-oxygen (ImmH to 9-deazainosine) increases the dissociation constant from 23 pM to 2.0 million pM. Substituents that induce small pK(a) changes at N-7 demonstrate modest loss of affinity. Thus, 8-F or 8-CH(3)-substitutions decrease affinity less than 10-fold. But a change in the deazapurine ring to convert N-7 from a H-bond donor to a H-bond acceptor (ImmH to 4-aza-3-deaza-ImmH) decreases affinity by >10(7). Introduction of a methylene bridge between 9-deazahypoxanthine and the iminoribitol (9-(1'-CH(2))-ImmH) increased the distance between leaving and oxacarbenium groups and increased K(i) to 91 000 pM. Catalytic site energetics for 20 substitutions in the transition-state analogue are analyzed in this approach. Disruption of the H-bond pattern that defines the transition-state ensemble leads to a large decrease in binding affinity. Changes in a single H-bond contact site cause up to 10.1 kcal/mol loss of binding energy, requiring a cooperative H-bond pattern in binding the transition-state analogues. Groups involved in leaving group activation and ribooxacarbenium ion stabilization are central to the H-bond network that provides transition-state stabilization and tight binding of the immucillins.lld:pubmed
pubmed-article:12463747pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:languageenglld:pubmed
pubmed-article:12463747pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:citationSubsetIMlld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12463747pubmed:statusMEDLINElld:pubmed
pubmed-article:12463747pubmed:monthDeclld:pubmed
pubmed-article:12463747pubmed:issn0006-2960lld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:TylerPeter...lld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:EvansGary BGBlld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:FurneauxRicha...lld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:SchrammVern...lld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:ShiWuxianWlld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:AlmoSteven...lld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:CahillSean...lld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:LewandowiczAn...lld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:KicskaGreg...lld:pubmed
pubmed-article:12463747pubmed:authorpubmed-author:FedorovAlexan...lld:pubmed
pubmed-article:12463747pubmed:issnTypePrintlld:pubmed
pubmed-article:12463747pubmed:day10lld:pubmed
pubmed-article:12463747pubmed:volume41lld:pubmed
pubmed-article:12463747pubmed:ownerNLMlld:pubmed
pubmed-article:12463747pubmed:authorsCompleteYlld:pubmed
pubmed-article:12463747pubmed:pagination14489-98lld:pubmed
pubmed-article:12463747pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:meshHeadingpubmed-meshheading:12463747...lld:pubmed
pubmed-article:12463747pubmed:year2002lld:pubmed
pubmed-article:12463747pubmed:articleTitleAtomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase.lld:pubmed
pubmed-article:12463747pubmed:affiliationDepartment of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.lld:pubmed
pubmed-article:12463747pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12463747pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12463747pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12463747pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:493724entrezgene:pubmedpubmed-article:12463747lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12463747lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12463747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12463747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12463747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12463747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12463747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12463747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12463747lld:pubmed